S. Mariathasan
Molecular Biology · 2000–2020
A researcher in the Science corpus: 12 papers; trusts 4 researchers and is trusted by 8 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 70 citations into it; #6,247 of 17,773 by trust here, #1,899 by citations
- Genetics — 8 citations into it
- Endocrinology — 7 citations into it
Whom S. Mariathasan trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts S. Mariathasan overall
- M. Lamkanfi
- P. Pelegrín
- J. Tschopp
- L. Franchi
- Vijay A. K. Rathinam
- Shizuo Akira
- S. Fink
- T. Kanneganti
- Kate Schroder
- Fabio Martinon
Papers from S. Mariathasan's perspective
Ordered by how strongly the researchers S. Mariathasan trusts endorse each paper. Same corpus, a different order for every researcher.
- IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. (Immunity)
- RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems (Nature)
- Bacterial adhesion and entry into host cells. (Cell)
- Toll-like receptor signalling (Nature reviews. Immunology)
- Salmonella interactions with host cells: type III secretion at work. (Annual Review of Cell and Developmental Biology)
- Intracellular pattern recognition receptors in the host response (Nature)
- Bacterial Invasion: The Paradigms of Enteroinvasive Pathogens (Science)
- A statistical model for identifying proteins by tandem mass spectrometry.
- Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf (Nature)
- Toll-like receptors: critical proteins linking innate and acquired immunity (Nature Immunology)
Their papers
- Cryopyrin activates the inflammasome in response to toxins and ATP (2006) — 3,164 citations
- Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf (2004) — 1,905 citations
- Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation (2007) — 921 citations
- Peripheral T cell expansion predicts tumour infiltration and clinical response (2020) — 630 citations
- Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial. (2020) — 630 citations
- Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial. (2018) — 1,232 citations
- TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells (2018) — 4,528 citations
- Atezolizumab as first-line therapy in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial (2016) — 1,904 citations
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single arm, phase 2 trial (2016) — 3,314 citations
- Novel antibody–antibiotic conjugate eliminates intracellular S. aureus (2015) — 737 citations
- Novel Staphylococcal Glycosyltransferases SdgA and SdgB Mediate Immunogenicity and Protection of Virulence-Associated Cell Wall Proteins (2013) — 68 citations
- Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b (2000) — 709 citations